Saltar al contenido
Merck
Todas las fotos(3)

Key Documents

View All Documentation

147966

Sigma-Aldrich

DL-Phenylalanine

99%, for peptide synthesis, ReagentPlus®

Sinónimos:

(±)-2-Amino-3-phenylpropionic acid

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(3)

About This Item

Fórmula lineal:
C6H5CH2CH(NH2)COOH
Número de CAS:
150-30-1
Peso molecular:
165.19
Beilstein/REAXYS Number:
3198807
EC Number:
205-756-7
MDL number:
MFCD00064225
UNSPSC Code:
12352209
PubChem Substance ID:
24848868
NACRES:
NA.22

product name

DL-Phenylalanine, ReagentPlus®, 99%

Quality Level

200

product line

ReagentPlus®

assay

99%

form

powder, crystals or granules

reaction suitability

reaction type: solution phase peptide synthesis

mp

266-267 °C (dec.) (lit.)

application(s)

peptide synthesis

SMILES string

NC(Cc1ccccc1)C(O)=O

InChI

1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)

InChI key

COLNVLDHVKWLRT-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

Phenylalanine is an amino acid. It participates in the preparation of ternary piroxicam complexes of Fe(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II). Characterization of these complexes by elemental analyses, molar conductance, IR, UV-Vis, magnetic moment, diffuse reflectance and X-ray powder diffraction methods has been conducted. Crystalline DL-phenylalanine was prepared by its reduction in silica gel by solubility method.

Application

DL-Phenylalanine may be used in the synthesis of ternary piroxicam (Pir; 4-hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide) complexes of Fe(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II).

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
SDBB0378
STBL0955
STBK7604
STBK5827
STBK4448

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 2

1 of 2

L-Phenylalanine certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Supelco

40541

L-Phenylalanine

DL-Alanine ≥99% (HPLC)

Sigma-Aldrich

A7502

DL-Alanine

XRD, thermal and FTIR studies on gel grown DL-Phenylalanine crystals.
Ramachandran E and Natarajan S.
Crystal Research and Technology, 42(6), 617-620 (2007)
Gehad G Mohamed et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 60(13), 3141-3154 (2004-10-13)
The ternary piroxicam (Pir; 4-hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide) complexes of Fe(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) with various amino acids (AA) such as glycine (Gly) or DL-phenylalanine (PhA) were prepared and characterized by elemental analyses, molar conductance, IR, UV-Vis, magnetic moment
Katarzyna M Romek et al.
Proceedings of the National Academy of Sciences of the United States of America, 112(27), 8296-8301 (2015-06-25)
Tramadol, previously only known as a synthetic analgesic, has now been found in the bark and wood of roots of the African medicinal tree Nauclea latifolia. At present, no direct evidence is available as to the biosynthetic pathway of its
Raja R Pillai et al.
The Journal of nutrition, 145(5), 954-959 (2015-03-13)
Lysine requirements of well-nourished children from developing regions have been found to be similar to those of children from developed regions (33.5 mg · kg⁻¹ · d⁻¹). However, intestinal parasites have been shown to increase lysine requirements in undernourished adults, and it is not
Sohei Nakayama et al.
Cancer research, 74(20), 5891-5902 (2014-08-29)
The discovery of somatic mutations in EGFR and development of EGFR tyrosine kinase inhibitors (TKI) have revolutionized treatment for lung cancer. However, resistance to TKIs emerges in almost all patients and currently no effective treatment is available. Here, we show
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico